These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34049465)

  • 21. Surface plasmon resonance spectroscopy for characterisation of membrane protein-ligand interactions and its potential for drug discovery.
    Patching SG
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt A):43-55. PubMed ID: 23665295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface Plasmon Resonance: A Useful Strategy for the Identification of Small Molecule Argonaute 2 Protein Binders.
    Poser E; Genovese I; Masciarelli S; Bellissimo T; Fazi F; Colotti G
    Methods Mol Biol; 2017; 1517():223-237. PubMed ID: 27924486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fragments: where are we now?
    Osborne J; Panova S; Rapti M; Urushima T; Jhoti H
    Biochem Soc Trans; 2020 Feb; 48(1):271-280. PubMed ID: 31985743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biophysics: for HTS hit validation, chemical lead optimization, and beyond.
    Genick CC; Wright SK
    Expert Opin Drug Discov; 2017 Sep; 12(9):897-907. PubMed ID: 28658992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [High-throughput Screening Technology for Selective Inhibitors of Transporters and Its Application in Drug Discovery].
    Motoyaji T
    Yakugaku Zasshi; 2021; 141(4):511-515. PubMed ID: 33790118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
    Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
    Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Off-rate screening (ORS) by surface plasmon resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction products.
    Murray JB; Roughley SD; Matassova N; Brough PA
    J Med Chem; 2014 Apr; 57(7):2845-50. PubMed ID: 24520903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fragment-based drug discovery using a multidomain, parallel MD-MM/PBSA screening protocol.
    Zhu T; Lee H; Lei H; Jones C; Patel K; Johnson ME; Hevener KE
    J Chem Inf Model; 2013 Mar; 53(3):560-72. PubMed ID: 23432621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integration of RNAi and Small Molecule Screens to Identify Targets for Drug Development.
    Drosopoulos K; Linardopoulos S
    Methods Mol Biol; 2019; 1953():33-42. PubMed ID: 30912014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developments in SPR Fragment Screening.
    Chavanieu A; Pugnière M
    Expert Opin Drug Discov; 2016; 11(5):489-99. PubMed ID: 26948323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regenerable Biosensors for Small-Molecule Kinetic Characterization Using SPR.
    Gunnarsson A; Stubbs CJ; Rawlins PB; Taylor-Newman E; Lee WC; Geschwindner S; Hytönen V; Holdgate G; Jha R; Dahl G
    SLAS Discov; 2021 Jun; 26(5):730-739. PubMed ID: 33289457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosensor-based small molecule fragment screening with biolayer interferometry.
    Wartchow CA; Podlaski F; Li S; Rowan K; Zhang X; Mark D; Huang KS
    J Comput Aided Mol Des; 2011 Jul; 25(7):669-76. PubMed ID: 21660516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
    Roy A; McDonald PR; Sittampalam S; Chaguturu R
    Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of fragment screening methods on the p38α kinase: new methods, new insights.
    Pollack SJ; Beyer KS; Lock C; Müller I; Sheppard D; Lipkin M; Hardick D; Blurton P; Leonard PM; Hubbard PA; Todd D; Richardson CM; Ahrens T; Baader M; Hafenbradl DO; Hilyard K; Bürli RW
    J Comput Aided Mol Des; 2011 Jul; 25(7):677-87. PubMed ID: 21732248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small-Molecule Library Subset Screening as an Aid for Accelerating Lead Identification.
    Beresini MH; Liu Y; Dawes TD; Clark KR; Orren L; Schmidt S; Turincio R; Jones SW; Rodriguez RA; Thana P; Hascall D; Gross DP; Skelton NJ
    J Biomol Screen; 2014 Jun; 19(5):758-70. PubMed ID: 24518067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A universal homogeneous assay for high-throughput determination of binding kinetics.
    Schiele F; Ayaz P; Fernández-Montalván A
    Anal Biochem; 2015 Jan; 468():42-9. PubMed ID: 25240173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acoustic Ejection Mass Spectrometry: A Fully Automatable Technology for High-Throughput Screening in Drug Discovery.
    Simon RP; Häbe TT; Ries R; Winter M; Wang Y; Fernández-Montalván A; Bischoff D; Runge F; Reindl W; Luippold AH; Büttner FH
    SLAS Discov; 2021 Sep; 26(8):961-973. PubMed ID: 34308708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragment screening for drug leads by weak affinity chromatography (WAC-MS).
    Ohlson S; Duong-Thi MD
    Methods; 2018 Aug; 146():26-38. PubMed ID: 29378316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.
    Heeres JT; Hergenrother PJ
    Chem Soc Rev; 2011 Aug; 40(8):4398-410. PubMed ID: 21140010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Fragment-Based Approaches to Discover New Antibiotics.
    Lamoree B; Hubbard RE
    SLAS Discov; 2018 Jul; 23(6):495-510. PubMed ID: 29923463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.